Money20/20 Europe 2025 Closes With Record Impact: Stablecoins, AI and Open Banking Take Center Stage
10.6.2025 12:28:00 EEST | Business Wire | Press release
Money20/20 , the world’s leading fintech show, and the place where money does business, has wrapped its Europe show in Amsterdam after three jam-packed days of the boldest conversations and biggest shifts in the European financial landscape. With thousands of attendees from over 2200 companies and nearly 100 countries, Money20/20 Europe has proved one thing: Europe isn’t playing catch-up – it’s shaping what’s next.
The event stages showcased a lineup of 450 industry leading speakers from 40 countries, with women representing 45% of all speakers. Compelling keynotes from financial powerhouses included Steven van Rijswijk, CEO at ING; Evelien Witlox, Director of Digital Euro at ECB; and TS Anil, CEO at Monzo to name a few.
Financial regulators gathered at the exclusive inaugural Money20/20 Policy Exchange for closed-door discussions aimed at accelerating innovation across three critical sectors: cryptocurrency regulation, Open Finance data access frameworks, and cross-border policy developed in partnership with the Bank for International Settlements (BIS)
Several major announcements were launched live – including from Revolut, Klarna & Visa, Mastercard & Deutsche Bank, Enfuce & Shuttle, Kraken & Ivy, LSEG, NYSE and NomuPay. Money20/20 in partnership with FXC Intelligence also launched the report How Will Europe’s Money Move in the Future? 2025’s View of 2035. A forward-looking, data-driven analysis of how Europe’s cross-border payments ecosystem is set to transform over the next decade.
The show also unveiled eight startups set to disrupt the industry, with Sinpex taking home the award for Money20/20’s Startup Pitch competition. The startups taking the briefing stage also included: Oscilar, AbbeyCross, Indicio, Carbon Equity, Esca, Nekod, and ChainComply.
Key themes from the show included the accelerating momentum behind stablecoins and digital currencies, AI’s fast-moving impact on fraud, identity, and personalised finance, and open banking’s evolution into an open data economy. Industry leaders debated Europe’s role in global fintech competitiveness, while regulation and sovereignty emerged as defining forces shaping the region’s financial future.
"This year's show was alive with optimism and intent to create the future of finance," said Suzy Pallett, Executive Vice President of Money20/20 Europe. "We saw regulators, banks, startups, and tech giants taking decisive action and making bold moves that will transform tomorrow's financial landscape. The energy was electric, and the connections made here will shape what comes next as we collectively create the future of Europe's financial ecosystem."
“Money20/20 continues to be a key milestone for us each year, making it the perfect stage to announce our new partnership with Deutsche Bank,” said Greg Ulrich, Chief AI Officer at Mastercard. “This will bring open banking-powered account-to-account payments to merchants across Europe.”
Money20/20, FINTECH.TV, Cheddar, and NYSE launched “Taking Stock” a game-changing new fintechTV show set to launch in mid August broadcasting live from the NYSE trading floor on 11 Wall Street and from major fintech events worldwide.
“The NYSE has long been a platform for partnership, where innovation begins and transformation takes shape,” said Joe Benarroch, Head of Content, Media Partnerships & Distribution, NYSE Group. “The launch of Taking Stock, in collaboration with Money2020, Fintech TV, and Cheddar, is a testament to our commitment to bringing fresh perspectives to the market conversation. Together, we’re opening new doors for storytelling and insight at the intersection of business, culture, technology, and finance.”
View source version on businesswire.com: https://www.businesswire.com/news/home/20250610688090/en/
Contacts
For more information, please contact:
Tina Loncaric
Global Head of Public Relations
tina@money2020.com
M: +1 469 288 5556
About Business Wire
For more than 50 years, Business Wire has been the global leader in press release distribution and regulatory disclosure.
www.businesswire.com
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
SWISSto12 and Mitsubishi Electric Corporation Announce Strategic Partnership14.9.2026 10:00:00 EEST | Press release
SWISSto12 today announced a memorandum of understanding (MoU) with Mitsubishi Electric Corporation (MELCO) (TOKYO: 6503) to pursue joint opportunities on advanced payloads, radio frequency (RF) products, and market development in Japan and the APAC region. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260914982179/en/ Masahiko Arai, Executive Officer and Group President, Defense & Space Systems, Mitsubishi Electric, and Dr. Emile de Rijk, Chief Executive Officer, SWISSto12 Joint opportunities will leverage MELCO’s extensive satellite system expertise and integration capabilities together with SWISSto12’s proprietary 3D-printing designs and processes that form the foundation of its next-generation payloads—smaller, lighter, highly performant, yet built in materially shorter timeframes. The MoU underscores growing market adoption of SWISSto12’s HummingLink payload technology that leverages 3D-printing, with more than 2,000 pr
U.S. FDA Accepts New Drug Application Under Priority Review for Takeda’s Zasocitinib in Moderate-to-Severe Plaque Psoriasis, with Potential to Redefine Oral Treatment Expectations14.9.2026 10:00:00 EEST | Press release
Takeda (TSE:4502/NYSE:TAK) announced that the U.S. Food and Drug Administration (FDA) accepted its New Drug Application (NDA) under Priority Review for zasocitinib (TAK-279) for the treatment of adults with moderate-to-severe plaque psoriasis. Zasocitinib is an investigational, next-generation, highly selective and potent oral tyrosine kinase 2 (TYK2) inhibitor, which demonstrated rapid, durable and consistent skin clearance in Phase 3 plaque psoriasis studies.1-3 Addressing unmet needs in psoriasis treatment “Despite progress in psoriasis care, there remains a need for highly effective oral therapies that also address the diverse and often challenging manifestations of psoriasis, including involvement of high-impact sites like the scalp,” said Andy Plump, M.D., Ph.D., president of R&D at Takeda. “Our Phase 3 data demonstrated rapid and durable skin clearance across various patient types and in high-impact and hard-to-treat areas. Based on the results across nearly 3,000 patients, zaso
Thales Builds Cryptographic Security for the Age of AI and Post-Quantum Computing14.9.2026 10:00:00 EEST | Press release
According to the 2026 Thales Data Threat Report, the threat of Harvest Now, Decrypt Later (HNDL) attacks was the top-cited risk, with 59% of organizations reporting that they are prototyping and evaluating post-quantum cryptography (PQC) algorithms to prepare for the quantum era. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260804748922/en/ ©Thales To help organizations turn this readiness into deployment,Thales, a global leader in advanced technologies, today announced the launch of Luna 8, its next-generation hardware security module. Designed for the transition to post-quantum cryptography, Luna 8 enables organizations to securely store, protect, and manage cryptographic keys with market-leading performance, scalability, and speed. As organizations face growing pressure from emerging quantum threats, expanding AI workloads and evolving stringent regulatory requirements, Luna 8 provides the performance, security and cryp
Focused Support Launches Cavok STRIKE to Expand Link-16 Participation Across the Joint Force14.9.2026 08:00:00 EEST | Press release
Focused Support LLC today announced the launch of Cavok STRIKE, an integrated software capability that expands the Link-16 tactical battlespace picture by enabling additional operational platforms to participate in the Link-16 network. Modern battlefields have increasing numbers of unmanned systems, sensors, and supporting platforms operating throughout the joint battlespace. The rapid proliferation of Group 1, 2, and 3 UAS, including both expendable and recoverable systems, has created a growing need to integrate these assets into the broader tactical network. Many of these platforms provide operationally relevant information but have historically remained outside the Link-16 network due to limitations in size, weight, power, platform integration complexity, or acquisition cost. Cavok STRIKE addresses this gap by enabling platforms to participate in the Link-16 network as non-command-and-control participants. This allows those platforms to interoperate with traditional Link-16 platfor
Fujirebio Expands Access to Blood-based Neurology Testing in Brazil with ANVISA Market Authorization for Lumipulse® G NfL Blood and Lumipulse G pTau 217 Plasma14.9.2026 08:00:00 EEST | Press release
H.U. Group Holdings Inc. and its wholly owned subsidiary Fujirebio today announced that the Brazilian Health Regulatory Agency (ANVISA) has granted market authorization for the Lumipulse G NfL Blood and Lumipulse G pTau 217 Plasma assays for use on the fully automated LUMIPULSE® G immunoassay platform in Brazil. “ANVISA authorization of the Lumipulse G NfL Blood and Lumipulse G pTau 217 Plasma assays marks another important step in our mission to expand access to reliable, clinically meaningful blood-based biomarkers for clinicians and patients worldwide,” said Christiaan De Wilde, CEO of Fujirebio Europe N.V. “By making both neurological biomarker assays available to laboratories on a single, fully automated platform, we are helping support more informed clinical decision-making across a broad range of neurological conditions and throughout the diagnostic pathway.” The Brazilian ANVISA authorizations are based on the already CE marked in vitro diagnostics (IVD) approvals of these two
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom